← FDA DRUG APPROVALS

FDA ANDA · ANDA203139

MEGESTROL ACETATE

Sponsor: TWI PHARMS

APPLICATION
ANDA203139
TYPE
ANDA
ORIGINAL APPROVAL
2014-08-27
LATEST ACTION
2020-02-21
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription

Products

MEGESTROL ACETATEPrescription
MEGESTROL ACETATE 125MG/ML · SUSPENSION · ORAL

Approval history

2020-02-21Labeling · Supplement 14 · standardAP
2015-06-08Labeling · Supplement 2 · standardAP
2014-08-27UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →